A field guide to testosterone care For the questions that matter.
FieldworkTHE TRT FIELD GUIDE
Menu
Reviews · 5 MIN READ

Enhanced TRT review: reconcile the entry offer with the continuing prescription

Editorial research · Clinical review not completed

Enhanced publishes an online testosterone service with bloodwork, clinician review and injections. Its main product page and separate TRT offer show different price units. A useful assessment follows the transaction from the opening charge through the actual prescription and later renewal.

We reviewed those official pages and the company's terms on October 13, 2026. We did not complete intake or checkout. This is a service-and-terms review, without patient testing, an independent pharmacy inspection or a claim that the company's performance promises predict a reader's results.

THE USEFUL PART, UP FRONT
  • The $49 display does not establish a continuing monthly total.
  • The dedicated TRT page identifies compounded testosterone cypionate.
  • Confirm supply commitment, state access and clinical follow-up before payment.

Treat the starting number as a question

The injection product page invites readers to get started for $49. It describes laboratory assessment, clinician consultation, medication and follow-up within the broader service. It does not clearly establish that $49 is the recurring price for every month of all those components, so that number should not be used as a complete ongoing budget.

Ask exactly what the first payment buys, whether another charge precedes dispensing and which written terms govern the selected offer. Our cost guide distinguishes an opening assessment from recurring medication and clinical access. A low entry amount can be useful information without settling the full cost of treatment.

Check the supply offer on its own terms

A separate Enhanced TRT page advertises one month at $199 per month, three months at a $179 monthly equivalent and six months at a $169 monthly equivalent. These are different supply commitments. Confirm whether the longer selections are collected upfront, how they renew and how they relate to the $49 starting display.

The same offer describes a refund if the clinician finds treatment inappropriate. That eligibility promise should not be expanded into an unrestricted cancellation right after prescribing or dispensing. Request the conditions for stopping, changing or returning an order. We have not tested a refund or verified a completed customer's billing experience.

The dedicated offer names compounded cypionate

Enhanced identifies testosterone cypionate and says its medication is compounded through licensed pharmacies. That is more specific than an unnamed hormone program, but it still leaves the dispensing pharmacy, concentration and complete ingredient list to confirm for the actual order. We have not independently checked each pharmacy qualification claimed in the marketing.

FDA states that compounded drugs are not FDA-approved and do not receive its usual premarket assessment for safety, effectiveness and quality. Our compounded-versus-approved guide explains why a familiar active ingredient does not establish approval of the finished product. Ask why a compound is proposed and what alternatives the clinician has considered.

Keep the clinical threshold separate from performance language

The company describes bloodwork and medical history reviewed by a licensed clinician before prescribing. The Endocrine Society recommends diagnosis through symptoms and consistently low testosterone, confirmed with repeat morning testing and investigation of the cause. The product page's emphasis on strength, recovery or drive cannot perform that assessment.

Ask which findings would lead to another explanation or a recommendation against TRT. Our testing discussion helps frame that question. A twelve-week calibration period advertised by the company is a description of its intended process, not evidence that every person will reach a particular result within that time.

Ask what happens when monitoring changes the plan

The product page names measures including testosterone, estradiol, hematocrit, PSA and metabolic markers. Find out who reviews them, how results are communicated and what happens if a result requires action. Listing tests does not show that the right response occurs for every patient or that all future testing is covered by the advertised price.

Discuss blood pressure and reproductive plans before treatment. FDA's updated labeling includes increased-blood-pressure warnings, and testosterone can conflict with near-term fertility goals. Read the fertility guide and monitoring article as preparation for professional advice, not as a plan for adjusting a prescription yourself.

Confirm the state and continuing contact

Ask whether the prescribing arrangement is available where you will receive care, including during travel. Enhanced mentions a coaching option with state limitations; clarify whether it is included and how coaching differs from clinical responsibility. An optional support service should not obscure who handles a medication concern.

Lowcountry Male offers a physical-clinic comparison with an insurance-qualified monthly display. Enhanced may interest someone seeking remote injectable care, provided the final agreement connects the starting charge, supply period, pharmacy and follow-up. Until that agreement is clear, the published figures are separate offers rather than proof of one all-inclusive price.

Sources & reading notes

Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Research checked October 13, 2026. Article updated October 13, 2026.

  1. Enhanced: testosterone injections and get-started offer (checked October 13, 2026)
  2. Enhanced: TRT supply offers and compounded cypionate (checked October 13, 2026)
  3. Enhanced: terms of service (checked October 13, 2026)
  4. Endocrine Society: testosterone therapy guideline (checked October 13, 2026)
  5. FDA: class-wide testosterone labeling changes (checked October 13, 2026)
  6. FDA: risks of compounded medicines (checked October 13, 2026)
This article is educational and cannot determine whether TRT is appropriate for you. Discuss diagnosis, treatment, and follow-up with a qualified clinician.